Active	Status	Sponsor type	Region	Phase	Filter
2 Active 8 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hayes, Daniel F
NCT00263913: 24 Months of Exemestane or Letrozole to Treat Breast Cancer	Active, not recruiting	N/A	160	US	Exemestane and letrozole, Letrozole	University of Michigan Cancer Center, Pfizer, Novartis	Breast Cancer	01/14	11/15
INACT, NCT06656663: INcreasing Adolescent Social and Community SupporT - Pilot	Active, not recruiting	N/A	78	Europe	Social Prescribing, Signposting	University College, London, University of Manchester	Loneliness	07/25	08/25